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BACKGROUND AND INTRODUCTION
Despite significant declines in maternal mortality rates, sub-Saharan Africa
continues to have a high burden of maternal mortality. Nigeria is one of 10
countries where women are most at risk of dying during childbirth and is
responsible for 14 percent of the world’s maternal deaths.

PE/E in Brief
•

Pre-eclampsia is a condition
in pregnant women marked by an
increase in blood pressure and
protein in urine after 20 weeks
gestation.

•

Providing high quality antenatal
care improves the prevention and
early detection of pre-eclampsia
and can prevent its progression to
eclampsia.

To fully understand the key challenges, gaps, and interventions related to the
prevention and treatment of PE/E, the Ending Eclampsia project conducted
a systematic review of papers on PE/E in Nigeria published between 20002015. The methods, results, and recommendations are discussed below.

•

Eclampsia is a life-threatening
condition characterized by
convulsions in women with
pre-eclampsia.

METHODS

•

Researchers designed two sets of key search terms related to pre-eclampsia
and eclampsia to capture references for peer-reviewed papers on PE/E
detection, management, and prevention. The searches were run in the following
bibliographic databases: PubMed, ScienceDirect, World of Science, Cochrane,
POPLINE, and Wiley Online Library, as well as google.com. Two independent
reviewers read and evaluated the results in three phases: Abstract and title
review, full text review, and categorization of papers (Figure 1).

Women in developing countries
are 300 times more likely to die
from eclampsia than women in
developed countries.

•

Prescribing low-dose aspirin and
calcium to at-risk women can
lower their risk of developing
pre-eclampsia and eclampsia.

•

Severe pre-eclampsia can be
managed by administering
anti-hypertensive drugs and
magnesium sulphate (MgSO4).

•

MgSO4 is the safest and most
effective treatment for severe
PE/E.

•

Pre-eclampsia and other
hypertensive disorders in
pregnancy increase the risk of preterm births, which can lead to low
birth weight, anemia, and stunting.

•

Improved prevention, increased
detection, and effective treatment
of PE/E can prevent unnecessary
maternal and newborn deaths.

Pre-eclampsia and eclampsia (PE/E), hypertensive disorders of pregnancy,
are consistently cited as a leading cause of maternal and newborn morbidity
and mortality Nigeria. A recent, nationwide cross-sectional survey found
that PE/E is the leading cause of maternal mortality in Nigeria, contributing
to 28.2 percent of national maternal deaths. he other main contributors to maternal
mortality are hemorrhage, at 24.4 percent, and pregnancy-related infection or
sepsis, at 14.2 percent.

In Phase I, reviewers evaluated abstracts to determine relevance. Abstracts
were excluded if they were:
1. Not about Nigeria;
2. Not related to pregnancy (e.g. abstracts about male subjects, children,
epilepsy, and other disorders); or
3. Not related to PE/E or any associated risk factors, symptoms, or complications.
The reviewers reconciled their results, and came to a consensus on any
discrepancies.
In Phase ll, to confirm the results the reviewers read the full texts of the
remaining citations to determine relevance and eliminated papers that were
not related to PE/E, did not primarily focus on Nigeria, or did not provide any
substantive data specific to Nigeria, and any papers without a full text.
Finally, the remaining articles were sorted into five categories—based on the
main topic of each—that were found during the systematic review.
1. Strategies that explored prevention or managment of PE/E;
2. Demonstrated and potential risk factors for pre-eclampsia;
3. Other health outcomes associated with PE/E;
4. Descriptive program summaries and literature reviews; and
5. Record reviews of hospital case files.
The goal was to identify articles with evidence on interventions that addressed
the prevention, diagnosis, and treatment of PE/E.
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The Ending Eclampsia project seeks to expand
access to proven,underutilized interventions and
commodities for the prevention, early detection,
and treatment of pre-eclampsia and eclampsia and
strengthen global partnerships.

FIGURE 1: Flow Chart of Review Process

the amount or frequency of doses may be as effective
and safe as the currently-accepted standard.
The literature indicates that cesarean section (CS),
conducted using spinal anesthesia, is likely the safest
mode of delivery for PE/E cases. However, if treatment is
successful, a woman can still delivery her baby vaginally.
While each of these strategies can potentially reduce
mortality due to PE/E, the most essential strategy
focuses on improving providers’ knowledge and skills for
detecting and managing obstetric emergencies, including
task shifting to primary facility providers.
Demonstrated and potential risk factors

RESULTS
After removing duplicate citations and those unrelated
to this review, 520 abstracts were included in Phase I.
The reviewers removed 338 articles that were deemed
to not fulfill the inclusion requirements for Phase I.
During Phase II, 37 articles were removed as they did not
provide enough, relevant Nigeria-specific information or if
a full text document could not be located. The systematic
review included 145 articles.
Five major themes emerged from the reviewed articles:
Strategies for prevention and treatment of PE/E,
demonstrated and potential risk factors, other health
outcomes associated with PE/E, program descriptions
and literature reviews, and hospital record reviews.
Strategies for prevention and management
Nineteen papers discussed strategies for detecting,
monitoring, and managing PE/E. The overarching findings
revealed effective case management occurs continually,
from detection to after delivery. Early management of
PE (before 30 weeks), using detailed monitoring charts
that allow providers to document patients’ health and
treatment4, and institutionalizing updated policies and
guidelines improve of quality care for women with PE/E.
Another strategy is early management of PE, incorporating
a tool that streamlines monitoring and treatment, and
another tests the role of serum magnesium levels in
eclamptic patients as a way to test for MgSO4 toxicity.
Four articles questioned the standard dosing regimen
for MgSO4 and suggested that the favored Pritchard
Regimen - four grams MgSO4 IV, five grams in each
buttock, followed by five grams in atlernate buttocks for
24 hours - may be excessive, and proposed that reducing
3

While the biological mechanism for developing preeclampsia remains unknown, many studies looked at
various attributes or conditions in an effort to confirm
or identify potential risk factors for developing PE/E.
Previously demonstrated risk factors for PE/E that appear
in the literature include low parity, young age, multiple
gestation, history of chronic high blood pressure (BP),
previous PE, and no antenatal care (ANC) visits.
Most of the articles investigated potential risk factors
relating to biomarkers in pregnancy. Various biological
measures were examined to determine if there were
observable trends or associations between the
biomarker and the development of PE/E. The literature
seems to indicate that elevated levels of haptoglobin,
malondialdehyde, phenylalanine concentration, blood
lead and homocysteine levels may contribute to the
development of PE/E. Similarly, low serum concentrations
of zinc, copper, manganese and magnesium, and low
plasma calcium, vitamin C, and E could also indicate preeclampsia or risk of pre-eclampsia in pregnant women.
Other potential risk factors explored in the literature were
change in paternity, maternal ethnicity, and sickle cell
anemia, though many studies were unable to draw firm
conclusions due to small sample sizes.
Other health outcomes
Women who experience PE/E are at increased risk
of cesarean section (CS), cardiac complications, and
chronic hypertension. Among the less-common outcomes
reported, there were orofacial injuries and loss of vision.
One article named paralysis as an outcome for one
patient, but did not provide clear etiology.
Another outcome of PE/E is HELLP syndrome, a
dangerous condition that complicates eclampsia with
hemolysis, elevated liver enzymes, and low platelets.
HELLP syndrome causes internal organs to shut down,
and if left untreated, the mother’s and fetus’ health,
will deteriorate and can lead to death. In addition to the
immediate maternal health outcomes, other newborn
health outcomes associated with PE/E are preterm birth,
low birth weight, fetal malnutrition, and low Apgar scores.

DISCUSSION

CONCLUSION AND RECOMMENDATIONS

Despite the wealth of information in the literature on PE/E
in Nigeria, gaps remain and require further research.

Throughout the development of a pregnancy, there
are many opportunities when PE/E can be prevented,
detected and managed; however, based on the literature,
certain gaps exist along this continuum of care.

Gaps in Prevention of PE/E
Globally, aspirin and calcium are thought to have a
protective effect for women at risk of PE/E. This is briefly
mentioned without supportive evidence on the incidence
of PE/E. The effectiveness and impact of prophylactic
aspirin and calcium are unknown in the Nigerian context.
Gaps in Detection of PE/E
Gaps affecting detection of PE/E include unclear
terminology and clinical definitions and low antenatal
care (ANC) attendance. Even when ANC is given, providers
and families are unaware of signs and symptoms of PE/E.
There is no consistency in terminology used or in clinical
definitions for those terms; each paper provides their
own definitions with some overlapping diagnosis criteria
for BP levels, proteinuria and other symptoms including
edema, headache, and visual disturbances.
The literature shows patients “booked” for ANC are less
likely to develop PE/E compared to “unbooked” women
but what the literature doesn’t show are details about
which services women receive during ANC and whether
or not they are counselled on danger signs in pregnancy.
Gaps in Management of PE/E
The literature supports use of MgSO4 to manage severe
pre-eclampsia and eclampsia, but the lowest effective
dose is unknown. The current literature omits the utility
of antihypertensive drugs to manage high BP in pregnant
women, which is a strategy to reduce the risk of stroke.
Despite the evidence demonstrating the safety and
effectiveness of MgSO4, its use remains low due to poor
availability, inadequate knowledge among communities ,
lack of guidelines on its use (or unawareness of these
guidelines), misinformation regarding who can administer
the drug, poor knowledge of health workers on its use, fear
of toxicity, little incentive for pharmaceutical companies
to commercialize the drug (no return on investment),
availability of less effective drugs (like diazepam), and
lack of support for policy change all contribute to the
underutilization of this safe and effective life-saving drug.
In addition to the relatively low use of MgSO4, there are
no studies that demonstrate the lowest effective dose
to manage PE/E. Some researchers have started
questioning and testing the dosage with preliminary
results indicating that a reduced dose—either in amount
delivered or timing of doses—can be as effective as the
generally-accepted Pritchard regimen.
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In order to have the greatest impact, we recommend a
multi-level set of interventions that increase community
awareness of symptoms of PE/E and ANC health seeking
behavior, improve and expand provider skills and
knowledge at multiple levels (including primary health
centers) for detecting and treating high BP in pregnancy
and PE/E throughout the developmental stages of
pregnancy.
To reduce the mortality associated with PE/E in Nigeria,
the global community and national stakeholders must:
Develop a common language and streamlined policies:
•

Develop simple terminology and associated
definitions for global use.

•

Advocate to hospital administrators and relevant
policymakers to ensure adherence to management
protocols and procurement of essential drugs.

Clarify and define management strategies and dosage:
•

Determine minimum effective dose for MgSO4.

•

Create and distribute clear and concise guidelines
and protocols for managing hypertension and PE/E
with antihypertensives and MgSO4.

•

Assess the impact of aspirin and/or calcium
prophylaxis in Nigeria.

Increase access to quality services:
•

Train and maintain healthcare providers on
recognizing PE/E, managing high BP with
antihypertensive drugs, when and how to administer MgSO4, and how to monitor for and treat
MgSO4 toxicity.

•

Train PHC providers to detect and provide initial
treatment (antihypertensives and MgSO4 loading
dose) for PE/E and refer to secondary facilities.

Engage Community:
•

Increase community awareness and access to ANC.

•

Educate community members on signs and
symptoms of PE/E and when and where to seek
treatment.

For the full report, visit www.endingeclampsia.org
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